APA (7th ed.) Citation

Sato, K., Yoshizawa, H., Seki, T., Shirai, R., Yamashita, T., Okano, T., . . . Watanabe, T. (2019). Chemerin-9, a potent agonist of chemerin receptor (ChemR23), prevents atherogenesis. Clinical Science, 133(16), 1779. https://doi.org/10.1042/CS20190336

Chicago Style (17th ed.) Citation

Sato, Kengo, et al. "Chemerin-9, a Potent Agonist of Chemerin Receptor (ChemR23), Prevents Atherogenesis." Clinical Science 133, no. 16 (2019): 1779. https://doi.org/10.1042/CS20190336.

MLA (9th ed.) Citation

Sato, Kengo, et al. "Chemerin-9, a Potent Agonist of Chemerin Receptor (ChemR23), Prevents Atherogenesis." Clinical Science, vol. 133, no. 16, 2019, p. 1779, https://doi.org/10.1042/CS20190336.